Results 151 to 160 of about 22,433 (204)

Comparative efficacy and safety of liraglutide versus metformin, naltrexone/bupropion, and phentermine-topiramate in psychiatric patients. [PDF]

Ther Adv Psychopharmacol
Choi WS, Song MK, Seo M, Woo YS, Bahk WM.   +4 more
europepmc   +1 more source

Formulation development and a Phase 1 clinical study of PF614-MPAR, an oxycodone prodrug with oral opioid overdose protection. [PDF]

J Opioid Manag
Kirkpatrick DL, Pestano LA, Evans C, Millard J, Levy J, Zann V, Pepper K, Schmidt WK.   +7 more
europepmc   +1 more source

Targeting Multiple Gut-Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy. [PDF]

Obes Sci Pract
Miras AD, Hussain M.
europepmc   +1 more source

Erratum: Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study [Corrigendum]. [PDF]

J Pain Res
europepmc   +1 more source

Authors' reply to the letter to the editor regarding "Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported". [PDF]

Korean J Pain
Hariyanto TI, Vatvani AD, Patel P, Yanto TA.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Naltrexone

Reactions Weekly, 2023
Abstract Use of opioid antagonists, particularly when delivered as an extended-release formulation, is a meaningful treatment option for individuals with opioid use disorder who are highly motivated to remain opioid abstinent or do not have access to agonist treatment.
Marina Tsoy-Podosenin, Evgeny Krupitsky
  +4 more sources

Naltrexone and Conventionality

The American Journal of Drug and Alcohol Abuse, 1978
This study examines the effect of conventionality on whether patients who were scheduled for naltrexone took it, and on treatment outcomes for patients who did take it. It is based on admission and case record data for 147 male opiate addicts who enrolled in New York Medical College's Multitrack Abstinence Program. Naltrexone-taking is examined against
F, Suffet, D C, Remine, E, Taleporos, R, Brotman   +3 more
openaire   +2 more sources